Researchers have developed a novel nuclear medicine probe that can detect synaptic density loss in the brain, a key biomarker for neurodegenerative diseases like Alzheimer's. The probe, using positron emission tomography (PET) imaging, has high imaging characteristics and is suitable for clinical trials and commercialization.
Richard L. Wahl, MD, has been recognized for his pioneering work in radioimmunotherapy, PET scans, and fusion imaging. His research has significantly contributed to understanding cancer prognosis, treatment response, and the importance of metabolic activity.
Simon Cherry has made significant contributions to biomedical imaging instrumentation and technology development, including microPET and hybrid PET/MRI systems. He is widely recognized for his work on molecular imaging and has received numerous awards for his achievements.
Researchers have demonstrated that combining targeted radionuclide therapy with immunotherapy can enhance treatment response and lead to a high cure rate in melanoma patients. This novel approach uses yttrium-86 (Y-86) NM600, which selectively targets tumors and delivers precise radiation doses.
Researchers from Zhejiang University developed a new way to improve automated systems, such as energy plants and airplanes, using polyhedral feasible set computation. This method efficiently analyzes current behaviors and time frames to predict the best next steps for optimal performance.
The study found that pollution levels in Hong Kong are mainly determined by tropical cyclone locations, with different impacts on PM10 and ozone levels. Tropical cyclones bring high concentrations of pollutants when located east or southeast of Hong Kong.